Summary A diversity of adhesive interactions occur between the cancer cell and host extracellular matrix which potentiate neoplastic expansion and metastatic dissemination. In miscellaneous malignant diseases, tumour progression has been obse'rved to be associated with alterations in adhesion molecule expression. Recently, circulating soluble intercellular adhesion molecules have been identified. In this study, serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) were determined in patients with gastric cancer. The study group consisted of 27 patients with previously untreated gastric adenocarcinoma. Four patients had stage 11, two patients stage IlIl and 21 patients stage IV disease according to the TNM classification. Nineteen patients had distant metastasis. The sera obtained from 18 healthy volunteers served as controls. Serum sICAM-1 and sE-selectin concentrations were determined by enzyme-linked immunosorbent assay (ELISA). In addition, we also studied other tumour-associated antigens, i.e. CEA and CA 19-9. Serum sICAM-1 levels were significantly increased in patients with gastric cancer (P < 0.0001). However, sE-selectin levels did not differ from the controls. sICAM-1 concentrations were also significantly higher in patients with distant metastasis and peritoneal spread (P = 0.0045 and P = 0.0157 respectively), whereas sE-Selectin levels were elevated only in patients with peritoneal metastasis (P = 0.033). Serum concentrations of sICAM-1 and sE-selectin correlated with CEA levels (P = 0.0013 and P = 0.003 respectively). Elevated levels of sE-selectin were associated with poorer prognosis (P = 0.0099), whereas sICAM-1 had no significant impact on survival. Our results suggest that increased sICAM-1 serum levels may reflect widespread disease and contribute directly to the progression of gastric cancer. Further investigation of the molecular mechanisms of adhesive tumour-host interactions may lead to a better understanding of the natural history of gastric cancer.
The outcome of patients with stomach cancer is extremely poor. Most cases are diagnosed at an advanced stage and the five-year survival rate is approximately 5-15% (Silverberg et al, 1992) . The major determinant of survival following gastric cancer appears to be the development of metastases. Identification of biomolecules involved in the progression and dissemination of gastric cancer has gained considerable interest in the recent decade. Attachment factors, proteinases, natural proteinase inhibitors and motility factors are being investigated in patients with gastric cancer (Honda et al, 1996; Schwartz, 1996) .
Adhesion molecules are distinct membrane surface receptors that participate in coordinating vital biological events such as morphogenesis, cell migration and intercellular communication (Springer, 1990; Carlos and Harlan, 1994; Frenette and Wagner, 1996a,b) . There is substantial evidence to suggest that cell-cell and cell-matrix adhesive interactions play a crucial role in tumorigenesis, tumour progression and in particular metastasis (Albelda, 1993; Juliano, 1987; Pauli et al, 1990; Tuszynski et al, 1997) . The expression, function and regulation of adhesion molecules are essential in these complex events and dysfunction or dysregulation of their equilibrium consequently results in disruption of normal cellular architecture and differentiation.
Intercellular adhesion molecule-1 (ICAM-1, CD54) is a member of the immunoglobulin supergene family of adhesion Received 1 October 1997 Revised 29 December 1997 Accepted 31 December 1997 Correspondence to: M Benekli, 14 Sokak, 43/3, 06490, Bah9elievler, Ankara, Turkey proteins which serves as the counter-receptor for a leucocyte integrin adhesion receptor, lymphocyte function-associated antigen-1 (LFA-1) (Marlin and Springer, 1987) . The interaction of ICAM-l and LFA-1 is important in the pathophysiology of the disease, including tumour progression and metastasis. ICAM-1 has been shown to be expressed on malignant cells in a number of haematological and non-haematological neoplasms.
Selectins are adhesion molecules that mediate the initial binding of leucocytes to microvascular endothelium by lectin-type interactions with carbohydrate ligands on corresponding target cells (Bevilacqua et al, 1991; Bevilacqua and Nelson, 1993) . E-selectin (CD62E) is detected on the surfaces of endothelial cells upon activation by cytokines and hence designated by prefix E-, which stands for endothelium. E-selectin binds to target cell surfaces by oligosaccharide recognition, specifically to sialyl-Lewis x (sLex).
sLex is not responsible for all E-selectin-mediated adhesion processes, and the sLea moiety (also known as CA 19-9), which has been shown to be expressed on adenocarcinomas of gastrointestinal tract, is also involved in E-selectin-mediated adhesion (Majuri et al, 1992) .
Adhesion molecules can be detected in soluble forms in the circulation, and raised levels have been reported in several conditions, including different neoplastic conditions, higher concentrations being associated with liver metastases in gastrointestinal cancers (Haming et al, 1991; Tsujisaki et al, 1991; Banks et al, 1993; Gearing and Newman, 1993; Pui et al, 1993; Christiansen et al, 1996) . However, effect on survival was determined only in patients with malignant melanoma, lymphomas and Hodgkin's disease (Harning et al, 1991; Pui et al, 1993; Christiansen et al, 1996) .
In this study, we analysed serum levels of sICAM-1 and sEselectin in patients with newly diagnosed gastric carcinoma and determined their relation with metastasis and effect on survival.
PATIENTS AND METHODS Patients and controls
Serum samples were collected from 27 patients with newly diagnosed gastric cancer between June 1995 and February 1996 at the Department of Medical Oncology, Hacettepe University Institute of Oncology, Ankara, Turkey. There were 18 males and nine females with a median age of 60 years (range 33-75). All patients had histologically proven gastric adenocarcinoma. Patient characteristics are shown in Table 1 . Staging was carried out according to the revised American Joint Committee on Cancer (AJCC) International TNM system, which is based on post-gastrectomy pathological staging. Four patients had stage II, two patients stage III and 21 patients stage IV disease. Nineteen of the stage IV patients had distant organ-tissue metastases and the remaining two had locally advanced disease. Eleven patients had peritoneal dissemination, whereas seven patients could not be evaluated for peritoneal involvement. Distant organ and lymph node involvement were documented by chest radiography, abdominal ultrasonography and computerized tomography. Endoscopic sonography, bone scanning and bone marrow aspiration and biopsy were performed, if needed, in selected patients. Surviving patients were followed for about one year with a median of 4 months.
The sera obtained from 18 age-and sex-matched healthy hospital personnel, including 11 men and seven women, served as controls. Their median age was 51 years (range 24-70 years).
Collection and storage of serum samples Blood samples were collected following non-traumatic venepuncture before the surgery and/or chemotherapy and allowed to clot at room temperature for 2 h. The aliquots were separated following centrifugation for 5 min at 2500 r.p.m. and stored at -30°C until assayed.
Assay of circulating sICAM-1 and sE-selectin Serum levels of circulating adhesion molecules sICAM-1 and sEselectin were measured with commercial sandwich ELISA assays (R&D Systems Europe, UK) according to the manufacturer's instructions. In brief, microtitre plates were coated with a monoclonal antibody against one epitope on sICAM-1 and sE-selectin. Standards and samples were transferred to the coated microtitre plates and incubated with streptavidin-horseradish peroxidase conjugate and a biotinylated antibody recognizing a second epitope on sICAM-1 and sE-selectin. A colour reaction was developed with tetramethylbenzidine and the absorbance was read at 450 nm with a correction wavelength of 620 nm.
Measurement of carcinoembryonic antigen and carbohydrate antigen 19-9
We also simultaneously measured the levels of CEA and CA 19-9, which are established tumour markers for gastric cancer, using commercially available IMMULITE CEA and CA 19-9 kits (DPC, CA, USA). CEA is also an adhesion molecule similar in 
RESULTS

Concentrations of circulating sICAM-1 and sE-selectin in gastric cancer
Serum concentrations of sICAM-1 in gastric cancer patients were significantly elevated, whereas sE-selectin levels did not differ from those in normal controls. sICAM-I and sE-selectin levels were 408.4 (202.2) ng ml-'vs 279.85 (95.80) (P < 0.0001) and 66.0 (46.0) ng ml-' vs 59.95 (32.40) ng ml-' (P = 0.4584) respectively ( Figure 1 ). As shown in Table 2 , serum levels of sICAM-1 were significantly increased in gastric cancer patients with distant organ ICAM-1 and E-selectin in gastric cancer 269 cE-selectin (ng ml-') ; however, the differences did not reach statistical significance (P = 0.144) (Figure 2 ). Adhesion molecule levels were also evaluated according to peritoneal involvement (Table 2 ). Higher levels of sICAM-were noted in patients with peritoneal spread [441.60 (174.6) ng ml-'] than in patients without peritoneal implants [296.0 (108.8) ng ml-'] (P = 0.0157). In patients with peritoneal involvement, sE-selectin concentrations were also significantly raised compared with patients without peritoneal metastases [84.0 (34.0) ng ml-' vs 51.0 (34.0) ng ml-'; P = 0.033] (Figure 3) .
Correlation of sICAM-1 and sE-selectin with tumour-associated antigens Serum levels of sICAM-1 and sE-selectin did not correlate with each other, nor with serum CA 19-9 levels (data not shown). A significant correlation was, however, found between CEA serum levels and the levels of both adhesion molecules sICAM-1 and sEselectin (moderate positive correlation, r = 0.50 and P = 0.00 13 vs r = 0.57 and P = 0.003 respectively).
Prognosis and the serum adhesion molecule levels ROC curve analysis revealed the presence of significant cut-off values for sICAM-1 (z = 4.42, one-tailed P < 0.001) and sEselectin (z = 1.88, one-tailed P = 0.03 1) with reasonable predictive values for metastasis. Cut-off levels for sICAM-and sE-selectin were determined as 380 ng ml-l and 70 ng ml respectively. Sensitivity, specificity and positive and negative predictive values were calculated according to the cut-off values (Table 3) . Gastric cancer patients with serum sE-selectin levels over 70 ng ml' proved to have a significantly shorter overall survival than those with lower serum concentrations (P = 0.0099) (Figure 4 ). Serum sICAM-1 levels did not significantly affect survival (P = 0.1390). Early death of the majority of the patients during follow-up might be responsible for this unexpected result. Finally, higher CEA levels, but not CA 19-9 levels, indicated worse prognosis (P = 0.0408 vs P = 0.2080).
DISCUSSION
Neoplastic transformation and the evolution to metastatic disease are characterized by a dramatic aberration in cellular cohesive British Journal of Cancer (1998) 78(2) Malignant cells possess many membrane surface antigens that sICAM-1 (ng ml-') regulate fundamental cellular functions, including the MHC antigens, differentiation antigens, tumour-specific receptors and :erum sICAM-1 and sE-selectin levels in gastric cancer patients tumour-associated antigens (Black, 1980) . These antigens are shed Dut peritoneal metastasis. Error bars represent the dispersion of Id sE-selectin values. Edges of each box correspond to 25th and into the circulation and usually reflect the extent of the disease.
tiles and the thicker middle bars indicate the medians Molecules mediating leucocyte-endothelium adhesion may serve as tumour-associated antigens in a variety of solid tumours (Black, 1980) . ICAM-1, together with MHC antigens, plays an important ns (Albelda, 1993; Juliano, 1987; Pauli et al, 1990;  role in the human immune response, involving T-cell activation et al, 1997). Adhesion proteins are involved in many of and other lymphocyte effector functions. ICAM-1 and MHC antitediate steps of metastatic cascade and are likely to show gens are frequently coexpressed on the gastric carcinoma cells -d changes in expression during malignant progression.
which may suggest a possible contribution of the immune system ells invade the surrounding connective tissue and are to the dissemination of the tumour (Koyama et al, 1992 ; Ishii et al, away from their primary localization after the disruption 1994). Moreover, adhesion molecule shedding from the surface of ,tions between neighbouring cells. Circulating tumour the cancer cell may represent an important mechanism for tumour Ihere selectively to the microvascular endothelium of the cells to escape immunosurveillance. econdary target organ site. This process is suggested to
In this report, we have demonstrated that concentrations of ted by organ-specific adhesion molecules, which are sICAM-1 are increased in gastric cancer, especially in patients on the endothelial cells of the preferred site and which with distant organ and peritoneal metastases. sE-selectin levels did 'homing receptors' (Pauli et al, 1990 ). These adhesion not differ from the controls in patients with gastric cancer and in have also been shown to facilitate tumour cell motility metastatic patients, but were elevated significantly in patients with British Joumal of Cancer (1998) ICAM-1 and E-selectin in gastric cancer 271 peritoneal metastases. For sICAM-1, these findings confirm data published previously in the literature. However, in contrast, only higher (> 70 ng ml-') sE-selectin levels indicated worse prognosis in survival analysis, although sICAM-1 levels had no significant impact on survival. Serum levels of sICAM-1 and sE-selectin were correlated with serum CEA levels, but not with CA 19-9 levels. The significant correlations found between sICAM-1 or sEselectin and CEA probably reflect the similar nature of these molecules, which function as adhesion molecules.
Little is known about the expression and functions of adhesion molecules in gastric cancer. ICAM-1 was shown to be expressed on the surface of primary and metastatic gastric carcinoma cells (Koyama et al, 1992; Ishii et al, 1994; Mayer et al, 1995; Nasu et al, 1997) , but no correlation with survival was found (Mayer et al, 1995) . Mizoi et al (1995) described positive staining of stromal macrophages with ICAM-I and of lymphocytes with LFA-1 along the invasive margin of gastric cancer, and suggested a possible role of ICAM-l/LFA-I interaction in host immune/inflammatory reaction.
Contradictory results have also been reported in the literature. Ura et al ( 1996) , in contrast to our study, demonstrated that the expression of ICAM-1 was inversely correlated with liver metastasis. Yasoshima et al (1996) also showed a reduced expression of ICAM-I and of LFA-1 and increased surface expression of P1 integrins in an experimental animal model of high-metastatic gastric cancer cell line.
Data on circulating adhesion molecules in gastric cancer are insufficient. Our results confirm and augment data reported by Tsujisaki et al (1991) , who detected increased levels of sICAM-1 in the sera of gastric cancer patients, with particularly higher levels in patients with liver metastases. They also demonstrated that both expression and shedding of ICAM-I antigen increased when cultured gastric carcinoma cells were treated with interferon-y. Banks et al (1993) examined the serum concentrations of adhesion molecules sE-selectin, sICAM-1 and cVCAM-1 in randomly selected cancer patients. The levels of all three adhesion receptors were found to be elevated in patients with gastrointestinal cancer, but the exact localization of the tumours were not specified.
Moreover, the significance of adhesion molecule levels in metastatic disease was not determined, but it was stated that 85% of all cases with epithelial tumours were metastatic. The prognostic significance of adhesion molecules were not determined in either study.
In conclusion, the results of this study provide strong circumstantial evidence that alterations in the expression and function of adhesion molecules may play a critical role in the aggressive behaviour of gastric cancer. We have shown that the serum concentrations of sICAM-I are significantly elevated in gastric cancer. The level of sICAM-1 reflected metastatic dissemination and correlated with a well-known tumour-associated antigen, CEA. The functional role and pathophysiological consequences of elevated levels of sICAM-1 need to be further investigated. The identification of the peculiar mechanisms of the adhesion molecule aberrations may lead to a better understanding of the natural history of gastric cancer and also of other solid epithelial malignancies.
